News tagged with cell lymphoma
Microsoft co-founder Allen treated for lymphoma
Nov 17, 2009 |
not rated yet |
0
(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Researchers find new way to attack inflammation in Graves' eye disease
Nov 06, 2009 |
not rated yet |
0
A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug rituximab. Inflammation around their eyes and damage to the ...
Immunotherapy demonstrates long-term success in treating lymphoma
Oct 30, 2009 |
not rated yet |
0
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high ...
New therapy for vasculitis will help patients avoid infertility and cancer
Oct 18, 2009 |
not rated yet |
0
Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, ...
Drug That Crosses Blood-Brain Barrier Reduces Formation of Brain Metastases in Mice
Sep 29, 2009 |
2.5 / 5 (2) |
1
(PhysOrg.com) -- The drug vorinostat is able to cross the blood-brain barrier and reduce the development of large metastatic tumors in mice brains by 62 percent when compared to mice that did not receive the drug, according ...
Protein complex key in avoiding DNA repair mistakes, cancer
Aug 05, 2009 |
4.7 / 5 (3) |
0
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Bcl6 gene sculpts helper T cell to boost antibody production
Jul 23, 2009 |
5 / 5 (1) |
0
Expression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists ...
Anti-inflammatory drugs may defeat a treatment-resistant type of cancer
Jun 24, 2009 |
not rated yet |
0
(PhysOrg.com) -- Effective drugs for treating a chemotherapy-resistant form of lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease.
Two targeted therapies likely better than one in patients with aggressive lymphoma
May 15, 2009 |
not rated yet |
0
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working ...
Drinking wine may increase survival among non-Hodgkin's lymphoma patients
Apr 21, 2009 |
not rated yet |
0
Pre-diagnostic wine consumption may reduce the risk of death and relapse among non-Hodgkin's lymphoma patients, according to an epidemiology study presented at the American Association for Cancer Research 100th Annual Meeting ...
Researchers Formulate Treatment Combination Lethal To Pancreatic Cancer Cells (w/Video)
Apr 20, 2009 |
not rated yet |
0
A combination of two targeted therapies packs a powerful punch to kill pancreatic cancer cells in the laboratory, Mayo Clinic cancer researchers report. With further testing of these drugs that are from classes of pharmaceuticals ...
Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients after seven years
Dec 09, 2008 |
not rated yet |
0
More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson ...
New therapy prevents dangerous side effect for lymphoma patients
Dec 09, 2008 |
5 / 5 (1) |
0
Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of ...
Researchers aim to over-stress already taxed mantle cell lymphoma cells
Nov 10, 2008 |
not rated yet |
0
Cancer cells are already stressed by the fast pace they require to grow and spread and scientists believe a little more stress just may kill them.
News from Cancer: Risk factors for deadly form of lymphoma
Jul 07, 2008 |
4.3 / 5 (7) |
0
A new study indicates that the incidence of mantle cell lymphoma, an aggressive type of non-Hodgkin's lymphoma, is on the rise, most frequently striking men, Caucasians and older individuals. The study, published in the August ...
- Pages: 1
